7.6(top 1%)
Impact Factor
8.4(top 1%)
extended IF
110(top 3%)
citing journals
citing authors

Most Cited Articles of Liver International in 2018

Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening2018193
Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future2018189
Hepatotoxicity of immune checkpoint inhibitors: An evolving picture of risk associated with a vital class of immunotherapy agents201898
Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure?201886
Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models201885
Infections complicating cirrhosis201877
The impact of treatment of hepatitis C with DAAs on the occurrence of HCC201875
The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis201871
Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case-control study201856
Bacterial infection-triggered acute-on-chronic liver failure is associated with increased mortality201855
Role and mechanisms of autophagy in acetaminophen-induced liver injury201852
Sarcopenic obesity in cirrhosis-The confluence of 2 prognostic titans201851
Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes201849
Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease201847
Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy201844
Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls201844
Frailty in advanced liver disease201844
Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib201842
Growth differentiation factor 15 predicts advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease201842
Towards HBV curative therapies201841
Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Non-invasive tests are enough201841
Combining albumin-bilirubin score with future liver remnant predicts post-hepatectomy liver failure in HBV-associated HCC patients201841
Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN)201841
Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011201841
Altered fatty acid-binding protein 4 (FABP4) expression and function in human and animal models of hepatocellular carcinoma201840